CAR-T cell therapy: a potential new strategy against prostate cancer

Prostate cancer (PCa) is one of the main causes of cancer-related death in men. In the present immunotherapy era, several immunotherapeutic agents have been evaluated in PCa with poor results, possibly due to its low mutational burden. The recent development of chimeric antigen receptor (CAR)-T cell...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Immunother Cancer
Autors principals: Schepisi, Giuseppe, Cursano, Maria Concetta, Casadei, Chiara, Menna, Cecilia, Altavilla, Amelia, Lolli, Cristian, Cerchione, Claudio, Paganelli, Giovanni, Santini, Daniele, Tonini, Giuseppe, Martinelli, Giovanni, De Giorgi, Ugo
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2019
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6794851/
https://ncbi.nlm.nih.gov/pubmed/31619289
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40425-019-0741-7
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars